Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Equity Average (2019 - 2025)

AVITA Medical filings provide 7 years of Equity Average readings, the most recent being -$11.7 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 239.4% to -$11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.7 million, a 239.4% decrease, with the full-year FY2025 number at -$6.1 million, down 122.69% from a year prior.
  • Equity Average hit -$11.7 million in Q4 2025 for AVITA Medical, down from -$9.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $117.3 million in Q2 2021 to a low of -$11.7 million in Q4 2025.
  • Median Equity Average over the past 5 years was $69.5 million (2023), compared with a mean of $57.1 million.
  • Biggest five-year swings in Equity Average: surged 72.78% in 2021 and later plummeted 239.4% in 2025.
  • AVITA Medical's Equity Average stood at $108.1 million in 2021, then fell by 20.08% to $86.4 million in 2022, then crashed by 35.14% to $56.0 million in 2023, then plummeted by 85.07% to $8.4 million in 2024, then plummeted by 239.4% to -$11.7 million in 2025.
  • The last three reported values for Equity Average were -$11.7 million (Q4 2025), -$9.8 million (Q3 2025), and -$8.7 million (Q2 2025) per Business Quant data.